09.24.2018
International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer (2018)
Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy-Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients